Causal reasoning identifies mechanisms of sensitivity for a novel AKT kinase inhibitor, GSK690693.
about
Leveraging systems biology approaches in clinical pharmacologyComparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytesReverse causal reasoning: applying qualitative causal knowledge to the interpretation of high-throughput data.GSK690693 delays tumor onset and progression in genetically defined mouse models expressing activated Akt.Construction of a computable cell proliferation network focused on non-diseased lung cells.Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks.Novel pancreatic endocrine maturation pathways identified by genomic profiling and causal reasoning.Discovery of 14-3-3 protein-protein interaction inhibitors that sensitize multidrug-resistant cancer cells to doxorubicin and the Akt inhibitor GSK690693.Causal analysis approaches in Ingenuity Pathway AnalysisTranscription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer.AKT signaling pathway activated by HIN-1 methylation in non-small cell lung cancer.Construction of biological networks from unstructured information based on a semi-automated curation workflow.Determination of minimal transcriptional signatures of compounds for target prediction.Genes associated with intestinal permeability in ulcerative colitis: changes in expression following infliximab therapy.Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing.Systems Biology Approaches for Compound Testing
P2860
Q28539118-EEA850BE-8224-47DB-A465-779E3F0B6DCCQ28730590-95CCE650-03CF-4DE8-BC2C-FABC53F02D19Q30699718-A3E0A79C-ECDF-423D-8F66-4ACA527E6C69Q33596707-1D184692-32C6-45EA-A3BA-D1206B80582FQ33948769-BC7EE1C1-E26E-4BB7-85E5-802ADF9950C3Q34288079-F81A573C-2336-47D8-A345-0FC3B92DA9ACQ34589738-60948427-27FE-49E0-B563-85596E0A82E2Q35143276-788C3992-D53D-4802-9D25-F5C3E1F40DAEQ37592031-1E97A6FD-A877-4FB3-B43D-89C63D6DF41DQ37716386-2155E47C-0EB6-41DD-BC0C-3184652F31B2Q39441173-4F34E900-A7E8-424D-B64C-015F6818354BQ40708629-9A87C067-B2B1-431A-9C70-C1B244588795Q42219330-AF056346-B239-43E0-98DE-E35CE053F9BDQ46936282-F71B99C0-CD05-492F-AD0D-0C71B950C7C7Q50119043-C9E5694B-CA36-42EE-B007-812E78E5A390Q57075201-6CE5D989-65B6-4628-8454-0CDDBD1F0030
P2860
Causal reasoning identifies mechanisms of sensitivity for a novel AKT kinase inhibitor, GSK690693.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Causal reasoning identifies me ...... T kinase inhibitor, GSK690693.
@ast
Causal reasoning identifies me ...... T kinase inhibitor, GSK690693.
@en
type
label
Causal reasoning identifies me ...... T kinase inhibitor, GSK690693.
@ast
Causal reasoning identifies me ...... T kinase inhibitor, GSK690693.
@en
prefLabel
Causal reasoning identifies me ...... T kinase inhibitor, GSK690693.
@ast
Causal reasoning identifies me ...... T kinase inhibitor, GSK690693.
@en
P2093
P2860
P356
P1433
P1476
Causal reasoning identifies me ...... KT kinase inhibitor, GSK690693
@en
P2093
Andrea L Matthews
Catherine E Ellis
Dexter Pratt
Emanuel F Petricoin
Joseph J Loureiro
Michael Macoritto
Rakesh Kumar
Stephen J Blakemore
P2860
P2888
P356
10.1186/1471-2164-11-419
P407
P577
2010-07-06T00:00:00Z
P5875
P6179
1046182548